...
首页> 外文期刊>Clinical and Translational Allergy >Mechanisms that limit proliferative potential of drug-specific LTT in drug-induced severe cutaneous adverse reaction patients
【24h】

Mechanisms that limit proliferative potential of drug-specific LTT in drug-induced severe cutaneous adverse reaction patients

机译:限制药物引起的严重皮肤不良反应患者中药物特异性LTT增殖潜力的机制

获取原文
           

摘要

Background / ObjectivePrior use of “lymphocyte transformation test” (LTT) suggestedthat it was less often positive in Stevens-Johnsonsyndrome (SJS), Toxic Epidermal Necrolysis (TEN), thanin other cutaneous reactions, with possible dependence onsampling date. We explored the possible role of inhibitoryco-receptors in LTT, using well-defined groups of patientswho reacted to carbamazepine (CBZ), or lamotrigine(LTG), sulfamethoxazole (SMX) and allopurinol (ALL).MethodThirty one cases of SJS/TEN, and controls patients withDRESS (21) or exposed without reaction (EWR; (20)) wereprovided by the RegiSCAR group. Peripheral mononuclearcells (PBMC) were tested by qRT-PCR for the expressionof the inhibitory co-receptors and their respective ligands:PD-1/PDL1, CTLA4/B7.1. LTT was performed withPBMCs by measuring H3-thymidine incorporation after 6days incubation with CBZ/LTG/ALL (10μg/ml), SMX(50μg/ml) or medium, in the presence or not of blockingantibodies. Stimulation index ≥ 2.5 was considered positive.Mann-Whitney U test was used for comparison of geneexpression level. A p value ≤0.05 was considered statisticallysignificant.ResultsPositive LTT was observed in 3/23 (13%) SJS/TEN and in2/18 (11%) DRESS tested during the acute phase, and 7/22(32%) SJS/TEN and 4/12 (33%) DRESS tested after recovery(late). LTT were all negative in EWR. As compared totheir expression in PBMC of EWR, i) overexpression ofCTLA4 and of B7.1 was found in acute and late SJS/TEN,respectively; ii) overexpression of PD-1 and PDL1 wasfound in acute DRESS. Combined addition of anti-CTLA4and anti-PDL1 mAbs to LTT cultures of SJS/TEN (2 CBZand 2 SMX) and DRESS (4 CBZ) increased drug-inducedproliferation index, even turning some negative LTT intopositive LTT (4 out of 8; 50%).ConclusionWe confirm that reactive T cells are rarely detected inacute phase of SCAR, and to a lesser extent after recovery.We show for the first time that CTLA4- and PD-1pathways are active in SJS/TEN and DRESS, respectively,and may contribute to the negative reactivity of LTT.The use of anti-CTLA4 and anti-PDL1 mAbs could helpto sensitize drug-specific LTT.
机译:背景/目的先前使用“淋巴细胞转化试验”(LTT)提示,史蒂文斯-约翰逊综合征(SJS),有毒表皮坏死溶解症(TEN)中的阳性率低于其他皮肤反应,并且可能依赖于采样日期。我们使用明确定义的对卡马西平(CBZ)或拉莫三嗪(LTG),磺胺甲恶唑(SMX)和别嘌呤醇(ALL)有反应的患者组,探讨了抑制性共受体在LTT中的可能作用。方法31例SJS / TEN, RegiSCAR组控制了患有DRESS(21)或无反应暴露(EWR;(20))的患者。通过qRT-PCR测试外周单核细胞(PBMC)抑制性共受体及其各自配体的表达:PD-1 / PDL1,CTLA4 / B7.1。在有或没有封闭抗体的情况下,与CBZ / LTG / ALL(10μg/ ml),SMX(50μg/ ml)或培养基孵育6天后,通过测量H3-胸苷掺入量,对PBMC进行LTT。刺激指数≥2.5被认为是阳性。使用Mann-Whitney U检验比较基因表达水平。 p值≤0.05被认为具有统计学意义。结果在急性期,在3/23(13%)SJS / TEN和in2 / 18(11%)DRESS和7/22(32%)SJS / TEN中观察到阳性LTT恢复后(晚)测试了4/12(33%)的着装。 LWR在EWR中均为阴性。与它们在EWR的PBMC中的表达相比,i)在急性和晚期SJS / TEN中分别发现了CTLA4和B7.1的过表达; ii)在急性DRESS中发现过表达PD-1和PDL1。在SJS / TEN(2 CBZ和2 SMX)和DRESS(4 CBZ)的LTT培养物中联合加入抗CTLA4和抗PDL1 mAb可以提高药物诱导的增殖指数,甚至可以将一些阴性LTT转变为阳性LTT(8分之4; 50% )。结论我们确认在SCAR的急性期很少检测到反应性T细胞,并且在恢复后的程度较小。我们首次证明CTLA4-和PD-1途径分别在SJS / TEN和DRESS中有活性,并且可能抗CTLA4和抗PDL1 mAb的使用可能有助于敏化药物特异性LTT。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号